Academy for Continued Healthcare Learning

Integrating Clinical Pharmacists Into Collaborative Care For Patients With T2D To Realize Early Benefits of Once-Weekly Insulin Regimens

The management of type 2 diabetes (T2D) is complex, requiring a multidisciplinary, patient-centered approach that accounts for individualized glycemic and weight goals, comorbidities, hypoglycemia risk, medication costs, and individual preferences. Therapeutic inertia and patient reluctance often delay insulin initiation and intensification in patients with persistent hyperglycemia despite multiple antihyperglycemic agents. The emergence of once-weekly basal insulin analogues represent a transformative advancement in T2D management, offering a simplified treatment paradigm to address common ba

Before you enroll

Is this the right course for you?

Integrating Clinical Pharmacists Into Collaborative Care For Patients With T2D To Realize Early Benefits of Once-Weekly Insulin Regimens is offered by Academy for Continued Healthcare Learning for pharmacists. Topics in this listing: Clinical practice.

Check the credit type and approval notes below against your credential. The provider handles enrollment, completion and the certificate.

Course details

Provider
Academy for Continued Healthcare Learning
Format
On demand
Profession
Pharmacists
Credit expiration
May 29, 2027
Registration
Free provider account required
Last checked
Oct 10, 2026
Language
English

Credits & eligibility

3.5 ACPE CPE

Provider-designated ACPE contact hours with a Universal Activity Number.

Listed roles: Pharmacist

Approval / program ID: 0396-0000-26-005-H04-P

State scope: No individual state acceptance claim is made in this listing.

ACPE

What’s free

Course access
$0
Assessment
$0
Certificate
$0
Credit reporting
$0 — no separate reporting fee identified

The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

How to earn your credit

  1. Create an ACHL account, complete the pretest, view the online activity, and score at least 66% on the posttest.
  2. Complete the evaluation. The certificate is immediately available at no fee.

Questions about this course

Is “Integrating Clinical Pharmacists Into Collaborative Care For Patients With T2D To Realize Early Benefits of Once-Weekly Insulin Regimens” completely free?

The recorded cost is $0 for learning, assessment and the certificate, with no separate reporting fee identified. Academy for Continued Healthcare Learning requires a free account. The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.

Which credit can I earn?

The provider lists 3.5 ACPE CPE. Recorded roles: Pharmacist. Match the individual track below to your credential and board before enrolling.

When can I take this course?

This is an on-demand activity in the current collection; follow the source link to begin. The recorded credit expiration date is 2027-05-29.

What do I need to do for the certificate?

Create an ACHL account, complete the pretest, view the online activity, and score at least 66% on the posttest. Complete the evaluation. The certificate is immediately available at no fee. Completion and certificate delivery are handled by Academy for Continued Healthcare Learning; saving this listing does not enroll you or claim credit.

Sources & verification

These are the primary pages supporting this listing. Course recognition and board acceptance should be confirmed for your credential before enrollment.

Your next credential

Free exam preparation for pharmacists

Preparing for an exam, too? Explore free practice questions and explanations on OpenExamPrep.

OpenExamPrepFree exam preparation

These are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.

Academy for Continued Healthcare LearningFree
Available on demand

Navigating Complexity in the Post-CDK4/6 Inhibitor Treatment Setting for Patients With ER+/HER2- mBC: Strategies for Optimally Integrating Next-Generation Oral SERDs

The management of hormone receptor–positive (HR-positive), human epidermal growth factor receptor 2–negative (HER2-negative) metastatic breast cancer (mBC) is undergoing rapid transformation, largely driven by the imperative to overcome acquired endocrine resistance, frequently mediated by somatic estrogen receptor 1 (ESR1) mutations. These mutations predict a lack of benefit from further aromatase inhibitor (AI) therapy, making the correct identification and subsequent targeting of these alterations critical for guiding treatment selection. Next-generation oral selective estrogen receptor deg

2 CME + moreOn demand
Checked Oct 10, 2026
DHA J-7 Continuing Education Program OfficeFree
Starts within 7 days

Winn ACH Grand Rounds: Management of Sepsis: What’s new in the Surviving Sepsis Campaign 2026 Guidelines

Location Faculty Accreditations Register OverviewThese Grand Rounds are aimed at offering high-quality, medically relevant presentations to healthcare workers throughout the Winn Army Community Hospital footprint. Grand Rounds takes place every third Thursday in the Patriot Auditorium and is video teleconferenced out to our Troop Medical Clinics. This activity allows our healthcare workers to improve clinical knowledge and patient outcomes. We present different topics with different presenters each month.For more information about this activity, please contact Ms. Lisa Tyler (Tyler, Lisa M CIV

1 CME + moreLive webinar
Oct 13, 2026, 7:30 AM EDT